Post-transplant cyclophosphamide versus antithymocyte globulin in patients with all treated in CR1 with allo-HCT from matched unrelated donors. A study from ALWP of the EBMT

This article has no abstract
Epistemonikos ID: 7b104f22b3e0ee5a01ae2db3ad4fb23e775c8b80
First added on: Feb 15, 2025